Skip to main content

AN OPEN-LABEL, SINGLE-DOSE, PHARMACOKINETICS STUDY OF VALTOCO® WITH OPEN-LABEL SAFETY PERIOD IN PEDIATRIC SUBJECTS WITH EPILEPSY

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

Neurelis, Inc

Start Date

August 10, 2022

End Date

April 30, 2024
 

Administered By

Pediatrics, Neurology

Awarded By

Neurelis, Inc

Start Date

August 10, 2022

End Date

April 30, 2024